Hims & Hers Health (HIMS) Net Margin (2020 - 2026)

Hims & Hers Health (HIMS) reported Net Margin of 15.15% for Q1 2026, down 2359.0% on a YoY basis from 0.67% in Q1 2025, and down 554.28% sequentially from 3.33% in Q4 2025.

Hims & Hers Health (HIMS) Net Margin (2020 - 2026) Analysis & Trends

Hims & Hers Health (HIMS) has 7 years of Net Margin data on file, last reported at 15.15% in Q1 2026.

  • For the quarter ending Q1 2026, Net Margin fell 2359.0% year-over-year to 15.15%; the trailing twelve-month figure through Mar 2026 stood at 0.56% (down 977.0% YoY), and the FY2025 full-year result was 5.47%, down 307.0% from the prior year.
  • Net Margin slipped to 15.15% in Q1 2026, from 3.33% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 18.82% in Q3 2024 to a low of 17.33% in Q2 2022.
  • A 5-year average of 1.47% and a median of 0.5% in 2023 frame the typical range for Net Margin.
  • Across the five-year window, Net Margin soared 8222 bps in 2022 and sank 2359 bps in 2026, its largest moves.
  • Tracing HIMS's Net Margin over 5 years: stood at 6.52% in 2022, then surged by 108 bps to 0.5% in 2023, then surged by 971 bps to 5.41% in 2024, then slumped by 38 bps to 3.33% in 2025, then slumped by 554 bps to 15.15% in 2026.
  • Business Quant data shows HIMS's Net Margin at 15.15% in Q1 2026, 3.33% in Q4 2025, and 2.63% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn 9.29%
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn 26.57%
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn -33.66%
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn 35.18%
6 RedHill Biopharma 21.32 Bn 21.32 Bn - -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn 5.03%
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn 24.30%
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn 4.16%
10 Hims & Hers Health 6.44 Bn 5.69 Bn 396.79 Mn -15.15%

Historic Data

Download Data
DateValue
Mar 31, 2026 -15.15%
Dec 31, 2025 3.33%
Sep 30, 2025 2.63%
Jun 30, 2025 7.80%
Mar 31, 2025 8.44%
Dec 31, 2024 5.41%
Sep 30, 2024 18.82%
Jun 30, 2024 4.21%
Mar 31, 2024 4.00%
Dec 31, 2023 0.50%
Sep 30, 2023 -3.34%
Jun 30, 2023 -3.44%
Mar 31, 2023 -5.28%
Dec 31, 2022 -6.52%
Sep 30, 2022 -13.01%
Jun 30, 2022 -17.33%
Mar 31, 2022 -16.04%
Dec 31, 2021 -36.79%
Sep 30, 2021 -21.49%
Jun 30, 2021 -15.08%